In vitro, recombinant TWEAK (100 ng/mL) induced phosphorylation of IκB and NFκB (p65) and also enhanced cell migration, invasion, and EMT maker expression in colorectal cancer cells. Here, NFKB1 is linked to colorectal cancer.